Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, Guggenheim Analyst Says

Key Points

• Guggenheim analysts have raised their price target for Tempus AI (NASDAQ:TEM) from $80.00 to $95.00, suggesting a potential upside of 22.85% from the current price.
• Tempus AI reported a quarterly revenue of $314.64 million, significantly outperforming analysts' expectations of $296.84 million, indicating an 89.5% year-over-year increase.
• Insiders at Tempus AI have sold a substantial amount of stock recently, with COO Ryan Fukushima selling shares worth over $1.3 million.

Tempus AI (NASDAQ:TEM - Get Free Report) had its price target boosted by stock analysts at Guggenheim from $80.00 to $95.00 in a research note issued on Friday,Benzinga reports. The brokerage currently has a "buy" rating on the stock. Guggenheim's target price points to a potential upside of 22.85% from the company's current price.

A number of other research analysts have also weighed in on TEM. Bank of America increased their price target on Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC restated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. Morgan Stanley raised their price target on Tempus AI from $65.00 to $68.00 and gave the stock an "overweight" rating in a report on Tuesday, August 12th. HC Wainwright boosted their price objective on Tempus AI from $90.00 to $98.00 and gave the stock a "buy" rating in a research report on Friday, September 12th. Finally, Piper Sandler restated a "neutral" rating on shares of Tempus AI in a report on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $71.83.

Tempus AI Trading Down 2.4%

Shares of NASDAQ TEM opened at $77.33 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The business has a fifty day simple moving average of $72.30 and a two-hundred day simple moving average of $61.59. Tempus AI has a twelve month low of $31.36 and a twelve month high of $97.79. The firm has a market cap of $13.43 billion, a PE ratio of -64.98 and a beta of 5.08.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The firm had revenue of $314.64 million for the quarter, compared to analysts' expectations of $296.84 million. During the same period last year, the firm earned ($6.86) EPS. The company's quarterly revenue was up 89.5% on a year-over-year basis. Tempus AI has set its FY 2025 guidance at EPS. Analysts expect that Tempus AI will post -6.15 earnings per share for the current fiscal year.

Insider Activity at Tempus AI

In related news, COO Ryan Fukushima sold 17,460 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total transaction of $1,303,389.00. Following the completion of the transaction, the chief operating officer directly owned 839,180 shares of the company's stock, valued at $62,644,787. This trade represents a 2.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Andrew Polovin sold 5,398 shares of the company's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $402,960.70. Following the completion of the sale, the executive vice president owned 132,056 shares of the company's stock, valued at $9,857,980.40. This trade represents a 3.93% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 601,787 shares of company stock worth $42,492,268. 26.27% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Tempus AI

Large investors have recently bought and sold shares of the business. Pathway Capital Management LP purchased a new stake in shares of Tempus AI in the 1st quarter valued at $8,576,000. SeaCrest Wealth Management LLC acquired a new stake in Tempus AI during the first quarter worth about $535,000. Sumitomo Mitsui Trust Group Inc. boosted its holdings in Tempus AI by 31.4% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Massachusetts Financial Services Co. MA increased its stake in shares of Tempus AI by 92.6% in the first quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company's stock valued at $27,926,000 after purchasing an additional 278,311 shares during the period. Finally, Cambridge Investment Research Advisors Inc. acquired a new stake in shares of Tempus AI during the first quarter worth $1,019,000. Institutional investors and hedge funds own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.